Engraftment and key toxicity rates by treatment group
. | Engraftment . | VOD . | TMA . | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Neutrophil . | Platelet . | Occurrences . | Deaths . | |||||||
No. . | % . | No. . | % . | No. . | % . | No. . | % . | No. . | % . | |
Total, n = 143 | 137 | 96 | 118 | 83 | 21 | 15 | 9 | 6 | 8 | 6 |
Standard, tac/mtx, n = 70 | 67 | 96 | 63 | 90 | 6 | 9 | 3 | 4 | 1 | 1 |
Experimental, siro/tac/mtx, n = 73 | 70 | 96 | 55 | 75 | 15 | 21 | 6 | 8 | 7 | 10 |
P | 1.00 | .03 | .06 | .37 | .06 |
. | Engraftment . | VOD . | TMA . | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Neutrophil . | Platelet . | Occurrences . | Deaths . | |||||||
No. . | % . | No. . | % . | No. . | % . | No. . | % . | No. . | % . | |
Total, n = 143 | 137 | 96 | 118 | 83 | 21 | 15 | 9 | 6 | 8 | 6 |
Standard, tac/mtx, n = 70 | 67 | 96 | 63 | 90 | 6 | 9 | 3 | 4 | 1 | 1 |
Experimental, siro/tac/mtx, n = 73 | 70 | 96 | 55 | 75 | 15 | 21 | 6 | 8 | 7 | 10 |
P | 1.00 | .03 | .06 | .37 | .06 |